The Bavarian Biotechnology Cluster with a focus on medical biotechnology offers a unique and internationally outstanding ecosystem - with over 500 companies from the biopharma sector, two universities of excellence, a large number of renowned research institutions and a strong financial investor landscape.
The cluster is home to a highly innovative biotech scene with hotspots in Munich (with Martinsried and Freising), Regensburg, Würzburg, Straubing and Nuremberg/Erlangen. These offer globally competitive framework conditions for innovation, company development and growth with specialized networks and modern infrastructure, supported by the BioM cluster organization through constructive dialogue with politics, science and industry. In addition, networking events provide a platform for all players in the industry. Delegation trips and partnering services also promote international collaborations.
Current trends such as personalized medicine, the use of artificial intelligence (AI) and advancing digitalization play a central role. These developments enable more precise diagnoses, individualized therapies and more efficient drug development.
Especially for founders, the cluster offers comprehensive advice, tailored coaching and an outstanding network of experts and investors.
The Bavarian Biotechnology Cluster is funded within the framework of the Cluster Initiative Bavaria.
The cluster has shown enormous growth over the last two decades and has established itself as one of the leading biotech locations in Europe and worldwide. Biotech companies, start-ups and established firms alike, benefit from the optimal conditions in the region: the direct proximity to numerous academic research institutions, investors, service providers and technology parks. The attractiveness of the Bavarian cluster is backed up by relevant representatives from the pharmaceutical industry.
Tailored programs such as the m4 Award and the Medical Valley Award of the Bavarian Ministry of Economic Affairs promote the translation of promising academic research into practice. These competitions offer scientific teams financial support totaling 2.5 million euros each and professional coaching to help them turn their innovative approaches into business start-ups.
The cluster offers comprehensive advice, coaching, training and mentoring programs as well as laboratory and office space in the various life science centers especially for prospective company founders. In addition, the BioM incubator MAxL (Munich Accelerator Life Sciences & Medicine) in Martinsried creates/offers optimal conditions for pre-seed projects and early-stage start-ups in the biotech and healthtech sector.